Fulgent Genetics, Inc. FLGT Net additions (releases) charged to costs and expenses
Net additions (releases) charged to costs and expenses at other companies
Other financials
Where this comes from
Reported directly by Fulgent Genetics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.
The official record: Fulgent Genetics, Inc.’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →
Ask your AI about Fulgent Genetics, Inc.'s net additions (releases) charged to costs and expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Fulgent Genetics, Inc.'s net additions (releases) charged to costs and expenses?
- Fulgent Genetics, Inc. (FLGT) reported net additions (releases) charged to costs and expenses of $1.19M in Q1 2026.
- How has Fulgent Genetics, Inc.'s net additions (releases) charged to costs and expenses changed year-over-year?
- Fulgent Genetics, Inc.'s net additions (releases) charged to costs and expenses decreased by 42.7% year-over-year, from $2.08M to $1.19M.
- What is the long-term trend for Fulgent Genetics, Inc.'s net additions (releases) charged to costs and expenses?
- Over 2 years (2021 to 2025), Fulgent Genetics, Inc.'s net additions (releases) charged to costs and expenses has grown at a -7.5% compound annual growth rate (CAGR), from $8.94M to $7.65M.